28 Oct New Clinical Lead for NCCN: Dr Stephen Laughton
We are excited to announce that NCCN’s new Clinical Lead is Dr Stephen Laughton, Paediatric Oncologist and Neuro-Oncologist, based at Starship Blood and Cancer Centre. Dr Laughton has been involved in paediatric oncology for over 20 years and his specific area of interest and expertise is the management of children with brain tumours.
Dr Laughton is also Starship’s Principal Investigator for COG (Children’s Oncology Group) and the Health Professional Representative on the Board of Child Cancer Foundation
Please refer to the official announcement from Te Aho o Te Kahu (Cancer Control Agency) here.